These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22885693)

  • 1. De novo creation of MG1655-derived E. coli strains specifically designed for plasmid DNA production.
    Gonçalves GA; Prazeres DM; Monteiro GA; Prather KL
    Appl Microbiol Biotechnol; 2013 Jan; 97(2):611-20. PubMed ID: 22885693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmid DNA production with Escherichia coli GALG20, a pgi-gene knockout strain: fermentation strategies and impact on downstream processing.
    Gonçalves GA; Prather KL; Monteiro GA; Carnes AE; Prazeres DM
    J Biotechnol; 2014 Sep; 186():119-27. PubMed ID: 24995846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering of Escherichia coli strains for plasmid biopharmaceutical production: scale-up challenges.
    Gonçalves GA; Prather KL; Monteiro GA; Prazeres DM
    Vaccine; 2014 May; 32(24):2847-50. PubMed ID: 24598722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced plasmid DNA production by enzyme-controlled glucose release and an engineered Escherichia coli.
    Ramírez EA; Velázquez D; Lara AR
    Biotechnol Lett; 2016 Apr; 38(4):651-7. PubMed ID: 26696535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified Escherichia coli B (BL21), a superior producer of plasmid DNA compared with Escherichia coli K (DH5alpha).
    Phue JN; Lee SJ; Trinh L; Shiloach J
    Biotechnol Bioeng; 2008 Nov; 101(4):831-6. PubMed ID: 18814292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering Escherichia coli to increase plasmid DNA production in high cell-density cultivations in batch mode.
    Borja GM; Meza Mora E; Barrón B; Gosset G; Ramírez OT; Lara AR
    Microb Cell Fact; 2012 Sep; 11():132. PubMed ID: 22992433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational engineering of Escherichia coli strains for plasmid biopharmaceutical manufacturing.
    Gonçalves GA; Bower DM; Prazeres DM; Monteiro GA; Prather KL
    Biotechnol J; 2012 Feb; 7(2):251-61. PubMed ID: 21913330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Potential of a Genome-Reduced
    Nguyen TT; Bui LM; Byun JY; Cho BK; Kim SC
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Biosynthesis of Plasmid DNA from Escherichia coli Applying Experimental Design.
    Passarinha LA
    Methods Mol Biol; 2021; 2197():135-150. PubMed ID: 32827135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of growth rate on plasmid DNA production and metabolic performance of engineered Escherichia coli strains.
    Wunderlich M; Taymaz-Nikerel H; Gosset G; Ramírez OT; Lara AR
    J Biosci Bioeng; 2014 Mar; 117(3):336-42. PubMed ID: 24012107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering of bacterial strains and vectors for the production of plasmid DNA.
    Bower DM; Prather KL
    Appl Microbiol Biotechnol; 2009 Apr; 82(5):805-13. PubMed ID: 19205691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing strategies to increase plasmid DNA production in Escherichia coli DH5α using batch culture.
    Islas-Lugo F; Vega-Estrada J; Alvis CA; Ortega-López J; Del Carmen Montes-Horcasitas M
    J Biotechnol; 2016 Sep; 233():66-73. PubMed ID: 27374404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-engineering of an Escherichia coli K-12 strain for the efficient production of recombinant human Interferon Gamma.
    Pandey R; Kumar N; Monteiro GA; Veeranki VD; Prazeres DMF
    Enzyme Microb Technol; 2018 Oct; 117():23-31. PubMed ID: 30037548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of growth conditions on plasmid DNA production.
    Silva F; Passarinha L; Sousa F; Queiroz JA; Domingues FC
    J Microbiol Biotechnol; 2009 Nov; 19(11):1408-14. PubMed ID: 19996695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Segregated growth kinetics of Escherichia coli DH5α-NH36 in exponential-fed perfusion culture for pDNA vaccine production.
    Munguía-Soto R; García-Rendón A; Garibay-Escobar A; Guerrero-Germán P; Tejeda-Mansir A
    Biotechnol Appl Biochem; 2015; 62(6):795-805. PubMed ID: 25556882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in host and vector development for the production of plasmid DNA vaccines.
    Mairhofer J; Lara AR
    Methods Mol Biol; 2014; 1139():505-41. PubMed ID: 24619702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous oxygen availability affects the titer and topology but not the fidelity of plasmid DNA produced by Escherichia coli.
    Jaén KE; Sigala JC; Olivares-Hernández R; Niehaus K; Lara AR
    BMC Biotechnol; 2017 Jul; 17(1):60. PubMed ID: 28676110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient production of myo-inositol in Escherichia coli through metabolic engineering.
    You R; Wang L; Shi C; Chen H; Zhang S; Hu M; Tao Y
    Microb Cell Fact; 2020 May; 19(1):109. PubMed ID: 32448266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering E. coli for improved microaerobic pDNA production.
    Jaén KE; Velazquez D; Delvigne F; Sigala JC; Lara AR
    Bioprocess Biosyst Eng; 2019 Sep; 42(9):1457-1466. PubMed ID: 31079222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of new plasmid DNA vaccine vectors with R1-based replicons.
    Bower DM; Prather KL
    Microb Cell Fact; 2012 Aug; 11():107. PubMed ID: 22889338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.